Occupational risks of blood exposure in the operating room

American Surgeon

Volumn 73, Issue 7, 2007, Pages 637-646

  Fry, Donald E ^a,b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b Michael Pine and Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; EFAVIRENZ; ENFUVIRTIDE; HEPATITIS B VACCINE; LAMIVUDINE; LOPINAVIR; PEGINTERFERON; PEGINTERFERON ALPHA2B; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN; ZIDOVUDINE;

ANTIVIRAL THERAPY; BLOODBORNE BACTERIUM; DISEASE CONTROL; HEALTH CARE PERSONNEL; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFECTION PREVENTION; NOTE; OCCUPATIONAL HAZARD; OPERATING ROOM; PATHOGENESIS; PATIENT CARE; QUALITY OF LIFE; UNITED STATES; VIROTHERAPY; VIRUS INFECTION; VIRUS TRANSMISSION; DISEASE TRANSMISSION; OCCUPATIONAL EXPOSURE; REVIEW; VIRUS HEPATITIS;

BLOOD-BORNE PATHOGENS; DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HUMANS; OCCUPATIONAL EXPOSURE; OPERATING ROOMS; UNITED STATES;

EID: 34548536549     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (70)

1. Trumbell ML, Greiner DJ. Homologous serum jaundice: an occupational hazard to medical personnel. JAMA 1951;145:965-8.
2. Kuh C, Ward WE. Occupational virus hepatitis: an apparent hazard for medical personnel. JAMA 1950;143:631-4.
3. Seeff LB, Koff RS. Evolving concepts of the clinical and serologic consequences of hepatitis B virus infection. Semin Liver Dis 1986;6:11-22.
4. Centers for Disease Control and Prevention. Recommendations for preventing transmission of human immunodeficiency virus and hepatitis B virus to patients during exposure-prone invasive procedures. MMWR Morb Mortal Wkly Rep 1991;40:1-9.
5. American College of Surgeons. Statement on the surgeon and HIV infection [ST-13]. 〈http://www.facs.org/fellows_info/statements/st-13.html〉. Accessed May 22, 2007.
6. American College of Surgeons. Statement on the surgeon and hepatitis [ST-22]. 〈http://www.facs.org/fellows_info/statements/st-22.html〉. Accessed May 22, 2007.
7. Occupational Safety and Health Administration. Occupational exposure to bloodborne pathogens: final rule. Fed Reg 1991;56:64175.
8. Centers for Disease Control and Prevention. Update - transmission of HIV infection during an invasive dental procedure - Florida. MMWR Morb Mortal Wkly Rep 1991;40:21-7, 33.
9. Lemon SM. Type A viral hepatitis: new developments in an old disease. N Engl J Med 1985;313:1059-67.
10. Reyes GR, Purdy MA, Kim JP, et al. Isolation of a cDNA from the virus responsible for enteric transmitted non-A, non-B hepatitis. Science 1990;247:1335-9.
11. Wang K-S, Choo Q-L, Weiner AJ, et al. Structure, sequence and expression of the hepatitis delta viral genome. Nature 1986;323:508-14.
12. Linnen J, Wages J Jr, Zhang-Keck Z-Y, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996;271:505-8.
13. Sureau C, Romet-Lemonne JL, Mullins JI, et al. Production of hepatitis B virus by a differentiated human hepatoma cell line after transfections with cloned circular HBV DNA. Cell 1986;47:37-47.
14. Choo Q-L, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-62.
15. Shapiro CN. Occupational risk of infection with hepatitis B and hepatitis C virus. Surg Clin North Am 1995;75:1047-56.
16. Fry DE. The ABCs of hepatitis. Adv Surg 1999;33:413-37.
17. Seeff LB, Koff RS. Evolving concepts of the clinical and serologic consequences of hepatitis B virus infection. Semin Liver Dis 1986;6:11-22.
18. Befeler AS, DiBisceglie AM. Hepatitis B. Infect Dis Clin N Am 2000;14:617-32.
19. Lee WM. Hepatitis B virus infection. N Engl J Med 1997;337:1733-45.
20. Zajac BA, West DJ, McAleer WJ, Scolnick EM. Overview of clinical studies with hepatitis B vaccine made with recombinant DNA. J Infect Dis 1986;13(Suppl):39-45.
21. Centers for Disease Control and Prevention Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers - a response to P.I. 100-607 The Health Omnibus Program Extension Act of 1988. MMWR Morb Mortal Wkly Rep 1989;38:3-37.
22. Shapiro CN, Tokars JI, Chamberland ME, American Academy of Orthopaedic Surgeons Serosurvey Study Committee. Use of hepatitis-B vaccine and infection with hepatitis B and C among orthopaedic surgeons. J Bone Joint Surg Am 1996;78:1791-800.
23. Centers for Disease Control and Prevention. Updated U.S. public health service guidelines for the management of occupational exposure to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR Morb Mortal Wkly Rep 2001;50:1-42.
24. Tabor E, Cairns J, Gerety RJ, Bayley AC. Nine-year follow up study of plasma-derived hepatitis B vaccine in a rural African setting. J Med Virol 1993;40:204-9.
25. Heptonstall J. Outbreaks of hepatitis B virus infection associated with infected surgical staff. CDR 1991;1:R81-5.
26. Harpaz R, von Seidlein L, Averhoff FM, et al. Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control. N Engl J Med 1996;334:549-54.
27. Spijkerman IJB, van Doom L-J, Jansssen MHW, et al. Transmission of hepatitis B virus from a surgeon to his patients during high-risk and low-risk surgical procedures during 4 years. Infect Control Hosp Epidemiol 2002;23:306-12.
28. Slusarczyk J, Hess G, Meyer zum Buschenfelde K-H. Association of hepatitis B e antigen (HBeAg) with the core of the hepatitis B virus. Liver 1985;5:48-53.
29. Heptonstall J, Incident Investigation Team. Transmission of hepatitis B to patients from four infected surgeons without hepatitis B e antigen. N Engl J Med 1997;336:178-84.
30. AIDS/TB Committee of the Society for Healthcare Epidemiology of America. Management of healthcare workers with hepatitis B virus, hepatitis C virus, human immunodeficiency virus, or other bloodborne pathogens. Infect Control Hosp Epidemiol 1997;18:349-63.
31. Asmuth DM, Nguyen HH, Melcher GP, et al. Treatments for hepatitis B. Clin Infect Dis 2004;39:1353-62.
32. Alter MJ. Epidemiology of hepatitis C. Hepatology 1997;26(Suppl 1):62S-5S.
33. Sheppard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005;5:558-67.
34. Koretz RL, Brezina M, Polito AJ, et al. Non-A, non-B posttransfusion hepatitis: comparing C and non-C hepatitis. Hepatology 1993;17:361-5.
35. Alter MJ. Community-acquired viral hepatitis B and C in the United States. Gut 1993;34(Suppl 2):517-9.
36. Matteson L, Sonnerborg A, Weiland O. Outcome of acute symptomatic non-A, non-B hepatitis: a 13 year follow-up study of hepatitis C markers. Liver 1993;13:274-8.
37. Alter MJ. Epidemiology of hepatitis C. Hepatology 1997;26:62S-5S.
38. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus infection and HCV-related chronic disease. MMWR Morb Mortal Wkly Rep 1998;47:1-39.
39. Massari M, Petrosillo N, Ippolito G, et al. Transmission of hepatitis C virus in a gynecological surgery setting. J Clin Microbiol 2001;39:2860-3.
40. Patel PR, Larson AK, Castel AD, et al. Hepatitis C virus infections from a contaminated radiopharmaceutical used in myocardial perfusion studies. JAMA 2006;296:2005-11.
41. Krause G, Trepka MJ, Whisenhunt RS, et al. Nosocomial transmission of hepatitis C virus associated with the use of multidose saline vials. Infect Control Hosp Epidemiol 2003;24:122-7.
42. Stark K, Hanel M, Berg T, Schreier E. Nosocomial transmission of hepatitis C virus from an anesthesiologist to three patients-epidemiologic and molecular evidence. Arch Virol 2006;151:1025-30.
43. Tallis GF, Ryan GM, Lambert SB, et al. Evidence of patient-to-patient transmission of hepatitis C virus through contaminated intravenous anaesthetic; ampoules. J Viral Hepat 2003;10:234-9.
44. De Ledinghen V, Trimoulet P, Mannant P-R, et al. Outbreak of hepatitis C virus infection during sclerotherapy of varicose veins: long-term follow-up of 196 patients. J Hepatol 2006;46:19-25.
45. Comstock RD, Mallonee S, Fox JL, et al. A large nosocomial outbreak of hepatitis C and hepatitis B among patients receiving pain remediation treatments. Infect Control Hosp Epidemiol 2004;25:576-83.
46. Forns X, Martinex-Bauer E, Feliu A, et al. Nosocomial transmission of HCV in the liver unit of a tertiary care center. Hepatology 2005;41:115-22.
47. Macedo de Oliveira A, White KL, Leschinsky DP, et al. An outbreak of hepatitis C virus infections among outpatients at a hematology/oncology clinic. Ann Intern Med 2005;142:898-902.
48. Duckworth GJ, Heptonstall J, Aitken C. Transmission of hepatitis C virus from a surgeon to a patient. The incident control team. Commun Dis Public Health 1999;2:188-92.
49. Esteban JI, Gomez J, Martell M, et al. Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med 1996;334:555-60.
50. Ross RS, Viazov S, Thromahlen M, et al. Risk of hepatitis C virus transmission from an infected gynecologist to patients: results of a 7-year retrospective investigation. Arch Intern Med 2002;162:805-10.
51. Ross RS, Viazov S, Roggendorf M. Phylogenetic analysis indicates transmission of hepatitis C virus from an infected orthopaedic surgeon to a patient. J Med Virol 2002;66:461-7.
52. Cody SH, Nainan OV, Garfein RS, et al. Hepatitis C virus transmission from an anesthesiologist to a patient. Arch Intern Med 2002;162:345-50.
53. Mawdsley J, Teo CG, Kyi M, Anderson M. Anesthetist to patient transmission of hepatitis C virus associated with non exposure prone procedure. J Med Virol 2005;75:399-401.
54. Stribling R, Sussman N, Vierling JM. Treatment of hepatitis C infection. Gastroenterol Clin N Am 2006;35:463-86.
55. Centers for Disease Control and Prevention. Highlights of analysis: Cases of HIV/AIDS and cases of AIDS. HIV AIDS Surveill Rep 2005;17:1-49.
56. Centers for Disease Control and Prevention. Exposure to blood - what health-care workers need to know, 2003. Available at: www.cdc.gov/ncidod/dhqp/ pdf/bbp/Exp_to_Blood.pdf. Accessed January 27, 2007.
57. Franco-Paredes C, Tellez I, del Rio C. Rapid HIV testing: a review of the literature and implications for clinicians. Curr HIV/AIDS Rep 2006;3:169-75.
58. Ko WF, Cello JP, Rogers SJ, Lecours A. Prognostic factors for the survival of patients with AIDS cholangiopathy. Am J Gastroenterol 2003;98:2176-81.
59. Centers for Disease Control and Prevention. Updated U.S. public health service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. MMWR Morb Mortal Wkly Rep 2005;54:1-17.
60. Centers for Disease Control and Prevention. Case controlled study of HIV seroconversion in health-care workers after percutaneous exposure to HIV-infected blood - France, United Kingdom, and United States. January 1988-August 1994. MMWR Morb Mortal Wkly Rep 1995;44:929-33.
61. Ciesielski C, Marianos D, Qu CY, et al. Transmission of human immunodeficiency virus in a dental practice. Ann Intern Med 1992;116:798-805.
62. Robert LM, Chamberland ME, Cleveland JL, et al. Investigation of patients of health care workers infected with HIV. The Centers for Disease Control and Prevention database. Ann Intern Med 1995;122:653-7.
63. Lot F, Seguier J-C, Fegueux S, et al. Probable transmission of HIV from an orthopedic surgeon to a patient in France. Ann Intern Med 1999;130:1-6.
64. Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents. Available at: http://aidsinfo.nih.gov/ ContentFiles/AdultandAdolescentGL.pdf. Accessed May 22, 2007.
65. Bartlett JA, Fath MJ, Demasi R, et al. An updated systematic overview of triple combination therapy in antiretroviral-naïve HIV-infected adults. AIDS 2006;20:2051-64.
66. Nishizawa T, Okamoto H, Konishi K, et al. A novel DNA virus (TTV) associated with elevated transaminase levels in post-transfusion hepatitis of unknown etiology. Biochem Biophys Res Commun 1997;241:92-7.
67. Houston F, Foster JD, Chong A, et al. Transmission of BSE by blood transfusion in sheep. Lancet 2000;356:999-1000.
68. Llewelyn CA, Hewitt PE, Knight RS, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004;363:417-21.
69. Quebbeman EJ, Telford GL, Wadsworth K, et al. Double gloving: protecting surgeons from blood contacts in the operating room. Arch Surg 1992;127:213-6.
70. Jensen SL, Kristensen B, Fabrin K. Double gloving as self protection in abdominal surgery. Eur J Surg 1997;163:163-7.